Advanced search
Publication Cover
The American Journal of Drug and Alcohol Abuse
Encompassing All Addictive Disorders
Volume 36, 2010 - Issue 2
Submit an article Journal homepage
998
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Open Label Trial of the Tolerability and Efficacy of Zonisamide in the Treatment of Alcohol Dependence

Clifford M. KnappDivision of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA
, Ph.D.,
Ofra Sarid-SegalDivision of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA
, M.D.,
Mark A. RichardsonDivision of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA
, Ph.D.,
Laurie Sickles ColaneriDivision of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA
, B.S.N.,
Maryam AfsharDivision of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA
, M.D.,
Eric DevineDivision of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA
, Ph.D.,
Chris C. StreeterDivision of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA
, M.D.,
Joanne Piechniczek-BuczekDivision of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA
, M.D. &
Domenic A. CirauloDivision of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USACorrespondence[email protected]
, M.D. show all
Pages 102-105 | Published online: 25 Mar 2010

REFERENCES

  • Johnson BA, Ait-Daoud N, Bowden Cl, DiClemente CC, Roache JD, Lawson K, Javors MA. Oral topiramate for treatment of alcohol dependence: A randomized controlled trial. Lancet 2003; 361:1677–1685.
  • Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O’Malley SS, Swift RM. Topiramate for treating alcohol dependence: A randomized controlled trial. JAMA 2007; 298:1641–1651.
  • Maryanoff BE, Costanzo MJ, Nortey SO, Greco MN, Shank RP, Schupsky JJ, Ortegon MP, Vaught JL. Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives. J Med Chem 1998; 41:1315–1343.
  • Knapp CM, Mercado M, Markley TL, Crosby S, Ciraulo DA, Kornetsky C. Zonisamide decreases ethanol intake in rats and mice. Pharmacol Biochem Behav 2007; 87:65–72.
  • Sarid-Segal O, Knapp CM, Burch W, Richardson M, Bhatia S, DeQuatro K, Afshar M, Richambault C, Sickles L, Devine E, Ciraulo DA. The anticonvulsant zonisamide reduces ethanol self-administration by risky drinkers. American J Drug Alc Abuse 2009; 35:316–319.
  • Park SP, Hwang YH, Lee HW, Suh CK, Kwon SH, Lee BI. Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients. Epilepsy Behav 2008; 2:102–108.
  • Fritz N, Glogau S, Hoffman J, Rademacher M, Elger CE, Helmstaedter C. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav 2005; 6: 373–381.
  • Werz MA, Schoenberg MR, Meador KJ, Loring DW, Ray PG, Kaul-Gupta R, Ogrocki P. Subjective preference for lamotrigine or topiramate in healthy volunteers: Relationship to cognitive and behavioral functioning. Epilepsy Behavior 2006; 8:181–191.
  • Knapp CM, Sarid-Segal O, Richardson M, Afshar M, Piechniczek-Buczek J, Koplow J, Ciraulo DA. The effects of topiramate on alcohol use and cognitive function in alcohol dependence. Alc Clin Exp Res Supp 2006; 30:107A.
  • Benton Al, de Hamsher KS. Multilinguial aphasia examination. Iowa City, IA: 1989.
  • Smith A. Symbol Digits Modalities Test. Los Angeles: Western Psychological Services, 1982.
  • First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) New York: Biometrics Research, New York State Psychiatric Institute, 2002.
  • Sobell LC, Sobell MB, Leo GI, Cancilla A. Reliability of a timeline method: Assessing normal drinkers’ reports of recent drinking and a comparative evaluation across several populations. Br J Addict 1988; 83: 393–402.
  • Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-ll. Addiction 1993; 88:791–804.
  • Seino M, Fujitani B. (Zonisamide) Clinical Efficacy and Use in Epilepsy. In Antiepileptic Drugs. Levy RH, Mattson RH, Meldrum, Perucca E, eds. Philadelphia, PA: Lippincott, Williams, and Wilkins, 2002; 885–891.
  • Starosta AN, Leeman RF, Volpicelli JR. The BRENDA model: Integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders. J Psychiatr Pract 2006; 12:80–89.
  • Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-AR). Br J Addict 1989; 84:1353–1357.
  • Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278–296.
  • Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50–55.
  • Anton RF, Moak DH, Latham PK. The Obsessive Compulsive Drinking Scale: A new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 1996; 53:225–231.
  • Selzer ML, Vinokur A, van Rooijen L. A self-administered short Michigan Alcoholism Screening Test (SMAST). J Studies Alc 1975; 36:11–126.
  • Skinner HA, Horn JL. Alcohol Dependence Scale: Users Guide. Toronto, Ontario: Toronto Addiction Research Foundation, 1984.
  • Arias A, Covault J, Feinn R, Kranzler H. Zonisamide for alcohol dependence: Preliminary analysis. Alc Clin Exp Res 2009; 33:116A.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.